Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of DQ-2466 in persistent or permanent atrial fibrillation
jRCT2080222155Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carvedilol in Atrial fibrillation (AFib) (3 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
carvedilol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080222155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222155.